Sanjivani Paranteral Ltd.
Snapshot View

34.90 -1.10 ▼-3.1%

09 February 2023, 03:05:00 PM
Volume: 5,787

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sanjivani.co.in
Market Cap 34.89 Cr.
Enterprise Value(EV) 36.74 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 5.68 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 6.15 Trailing Twelve Months Ending 2022-09
Industry PE 30.86 Trailing Twelve Months Ending 2022-09
Book Value / Share -5.02 Trailing Twelve Months Ending 2022-09
Price to Book Value -6.95 Calculated using Price: 34.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.00 Cr. 9,998,300 Shares
FaceValue 10
Company Profile
Sanjivani Parenteral was established in 1997 by A H Khemka, Ashwin Khemka and Somesh Khemka, under the technical direction of Mahendra Kalwankar. It is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices. The core product range of the company's products includes oral solids, small volume parenterals and sterile powder formulations.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.06%
1 Week
-4.38%
1 Month
-10.63%
3 Month
-28.70%
6 Month
-28.92%
1 Year
-39.25%
2 Year
+232.38%
5 Year
+504.85%
10 Year
+66.99%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 4.66 -7.19 -58.98 -596.93
Return on Capital Employed (%) 12.18 5.69 -7.28 -33.04 -227.28 -265.98 266.43
Return on Assets (%) 1.38 -2.09 -14.16 -34.18 -124.34 -9.62 -10.16 8.13 25.80

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 35 32 18 -9 -53 -47 -49 -45 -8 -5
Non Curr. Liab. 8 7 14 9 6 10 9 7 4 2
Curr. Liab. 74 75 62 61 72 56 55 58 22 20
Minority Int.
Equity & Liab. 117 114 93 60 25 18 16 19 18 17
Non Curr. Assets 27 16 23 17 16 11 12 10 11 8
Curr. Assets 90 98 70 43 9 7 4 9 8 9
Misc. Exp. not W/O
Total Assets 117 114 93 60 25 18 16 19 18 17

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 159 133 115 33 18 25 16 25 31 31
Other Income 3 1 1 3 0 1 0 0 2 0
Total Income 161 135 116 36 18 26 17 25 32 31
Total Expenditure -149 -128 -121 -56 -70 -27 -17 -23 -26 -24
PBIDT 12 7 -5 -20 -52 -1 0 2 6 7
Interest -8 -8 -9 -5 0 0 -1 0 0 0
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation -1 0 0 0 0 0 0 0 0 0
Exceptional Items 0
PAT 2 -2 -15 -26 -53 -2 -2 1 5 6
Adjusted EPS 3 -4 -25 -44 -90 -4 -3 2 5 6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 7 9 -1 0 10 3 2 0 1 9
Cash Fr. Inv. -1 -1 9 -1 0 0 0 0 0 -1
Cash Fr. Finan. -6 -8 -7 -1 -10 -3 -2 0 0 -8
Net Change 0 0 0 -1 0 0 0 0 0 0
Cash & Cash Eqvt 1 1 1 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 8.36 24.63 24.63 19.85 27.35 27.35 27.35 27.35 27.35
Public 91.64 75.37 75.37 80.15 72.65 72.65 72.65 72.65 72.65
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 06 Feb 2023
Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Of The Company For The Quarter Ended December 31 2022
SANJIVANI PARANTERAL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of Sanjivani Paranteral Limited will be held on Tuesday 14th February 2023 inter alia 1. To consider and approve the Un-Audited Financial Results of the Company for the quarter ended December 31 2022. 2. Any other matter with the permission of the chair.
Wed, 11 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Please find enclosed herewith the Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 received from M/s Link Intime India Pvt Ltd. The Registrar and Transfer Agent of the Company for the quarter ended December 31 2022.
Sat, 07 Jan 2023
Closure of Trading Window
As per Securities And Exchange Board Of India (Prohibition Of Insider Trading) (Second Amendment) Regulations 2019 has mandated the closure of Trading window from the end of the quarter till the 48 hours from the declaration financial results.In view of the aforesaid it is hereby intimated that the trading window for dealing in Securities of the Company will remain closed for all Directors Officers Designated Persons of the Company and their immediate relatives with effect from Sunday January 01 2023 till 48 hours after the declaration of Un-Audited Financial Results of the Company for the quarter ended December 31 2022.

Technical Scans View Details >>

Wed, 08 Feb 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 6 Months High Decrease in 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.75 -0.6%
Cipla Ltd. 83,886.47 1,021.10 -1.7%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,488.85 +0.0%
Divi's Laboratories Ltd. 74,340.49 2,822.70 +0.8%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,385.35 -0.1%
Torrent Pharmaceuticals Ltd. 52,675.65 1,539.90 -1.1%
Zydus Lifesciences Ltd. 47,993.66 473.80 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.75 -0.6%
Cipla Ltd. Consolidated 2022-12 31.80 1,021.10 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,488.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,822.70 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,385.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,539.90 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 473.80 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.75 -0.6%
Cipla Ltd. Consolidated 2022-12 3.70 1,021.10 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,488.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,822.70 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,385.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,539.90 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 473.80 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.75 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,021.10 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,488.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,822.70 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,385.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,539.90 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 473.80 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.75 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,021.10 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,488.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,822.70 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,385.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,539.90 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.80 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.75 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,021.10 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,488.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,822.70 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,385.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,539.90 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.80 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.75 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,021.10 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,488.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,822.70 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,385.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,539.90 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 473.80 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.75 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,021.10 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,488.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,822.70 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,385.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,539.90 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 473.80 0.0%

FAQ's On Sanjivani Paranteral Ltd.

What is Sanjivani Paranteral share price?

Can I buy Sanjivani Paranteral shares now?

What is the Market Cap of Sanjivani Paranteral?

What are the key metrics to analyse Sanjivani Paranteral?

What is the 52 Week High and Low of Sanjivani Paranteral?

What is the trend of Sanjivani Paranteral share price?